Information about forums, live demonstrations, Accelerating Talents and panel discussion. The entire forum program is available in the event database.
Presentation Hall B2 SEMICON EUROPA > SMART MedTech > Global Perspectives in Healthcare
10:05-10:30 h | Hall B2 Inspiration Hub, Booth B2.261
Subjects: SEMICON EUROPA
Chairman: Cassandra Melvin (Director of Operations, SEMI Europe)
Over the last 200 years, there has been significant advances in average life expectancy. At the same time, there has been an increase in the number of chronic conditions that we have as we age. So, in some sense, we are living, longer, unhealthier lives. What if we could predict who was going to get disease and then pre-empt it from happening? That vision could lead to a world without disease. This presentation will discuss strategies to live into this vision, and potential steps toward achieving it.
Johnson & Johnson
Benjamin C. Wiegand, Ph.D. is the Global Head of the World Without Disease Accelerator, Janssen R&D. This effort is a critical element in Janssen’s efforts to catalyze a new paradigm in health care, with the potential to capitalize on the expertise across all of J&J. The focus of the World Without Disease Accelerator is to address the root cause(s) of disease, and then either prevent, intercept and cure the disease. This will lead to interventions much earlier than today’s clinically accepted point of diagnosis and will lead to the eradication of the targeted disease. These efforts require both technical and business model innovation to create this new healthcare paradigm. As the leader of the WWD Accelerator, Ben is responsible for developing and implementing strategies that will deliver solutions in a World Without Disease paradigm. Today, the focus of the WWDA is on three areas, Lung Cancer, Type 1 Diabetes and Colorectal Cancer. In addition, his team has expertise in six critical enabling capabilities, Immunosciences, Microbial Therapeutics, Sensors & Wearables, Gene Editing, Data Sciences, and Behavioral Neurobiology, which are coupled with digital technologies to activate and change the trajectory of health for consumers around the world.Ben has worked at Johnson & Johnson for over 20 years, with experiences in a wide range of the Johnson & Johnson Consumer businesses. He has a broad range of experience in both short term product development as well as long term innovation. In that role, he was named a 2008 Johnson Medal recipient for his work on key behavioral studies of the effect of rituals in improving infant sleep behaviors.Ben holds a B.S. degree in Chemistry from the University of Illinois, and both a M.A. and Ph.D. in Physical Chemistry from Harvard University.